Furthermore, it addresses the FDA’s communications Along with the applicant, the retention of data that aid the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer ownership of the SE report to a brand new applicant and electronic submission on the SE report and amendment